Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene

International Journal of Cancer

Volumn 92, Issue 2, 2001, Pages 309-310

  Mschen, Markus ^a   Re, Daniel ^a   Betz, Beate ^a   Moers, Cordula ^a   Wolf, Jrgen ^a   Niederacher, Dieter ^a   Diehl, Volker ^b   Beckmann, Matthias W ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Apoptosis; Breast cancer; CD95; Somatic mutation; Tumor suppressor gene

Indexed keywords

FAS ANTIGEN;

APOPTOSIS; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER CELL CULTURE; CANCER GRADING; EXON; GENOME; HETEROZYGOSITY LOSS; HUMAN; LUNG NON SMALL CELL CANCER; MELANOMA; PRIORITY JOURNAL; SOMATIC MUTATION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ANTIGENS, CD95; APOPTOSIS; BREAST NEOPLASMS; FEMALE; HUMANS; MUTATION; TUMOR CELLS, CULTURED;

EID: 0035871978     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200102)9999:9999<::AID-IJC1188>3.0.CO;2-5     Document Type: Article

References (13)

1. Defining CD95 as a tumor suppressor gene
2. Sponatneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions
3. Mutations in the Fas antigen in patients with multiple myeloma
4. Somatic FAS mutations in non-Hodgkin's lymphoma: Association with extranodal disease and autoimmunity
5. Somatic mutations of the CD95 gene in Hodgkin- and Reed-Sternberg cells
6. Alterations of Fas (Apo-1/CD95) gene in transitional cell carcinomas of urinary bladder
7. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer
8. Alterations of Fas (Apo-1/CD95) in cutaneous malignant melanoma
9. Somatic mutations of Fas (Apo-1/CD95) gene in cutaneous squamous cell carcinoma arising from a burn scar
10. CD95 ligand expression in dedifferentiated breast cancer
11. CD95 ligand expression as a mechanism of breast cancer
12. Death pathway genes Fas (Apo-1/CD95) and Bik (Nbk) exhibit no mutations in colorectal carcinomas
13. Analysis of Fas/CD95 gene somatic mutations in ovarian cancer cell lines